Harr Steve
CFO & Head, Corp. Development at Juno Therapeutics, Inc.
- Sold, on record
- $5.2M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Dec 21, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Juno Therapeutics, Inc.CFO & Head, Corp. Development
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Juno Therapeutics, Inc.Plan not statedDec 10, 2015 2015
Sold 35,000 shares at $46.43 ($1.6M)
Harr Steve, Officer
Sold 4.4% of holdings ($37.1M position)765,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale Juno Therapeutics, Inc.Plan not statedMar 1, 2016 +82 days
Sold 30,000 shares at $37.58 ($1.1M)
Harr Steve, Officer
Sold 3.9% of holdings ($28.7M position)735,000 shares leftFiling
- 3 Form 4 sale Juno Therapeutics, Inc.Plan not statedMar 4, 2016 +3 days
Sold 5,000 shares at $45.00 ($225k)
Harr Steve, Officer
Sold 0.7% of holdings ($33.1M position)730,000 shares leftFiling
- 4 Form 4 sale Juno Therapeutics, Inc.Plan not statedJun 10, 2016 +98 days
Sold 30,000 shares at $43.32 ($1.3M)
Harr Steve, CFO & Head, Corp. Development
Sold 4.1% of holdings ($31.6M position)700,000 shares left1x usual sizeFiling
- 5 Form 4 sale Juno Therapeutics, Inc.Plan not statedJun 27, 2017 +382 days
Sold 8,750 shares at $30.00 ($263k)
Harr Steve, CFO & Head, Corp. Development
Sold 1.2% of holdings ($22.1M position)727,439 shares left0.3x usual sizeFiling
- 6 Form 4 sale Juno Therapeutics, Inc.Plan not statedJul 3, 2017 +6 days
Sold 8,750 shares at $30.00 ($263k)
Harr Steve, CFO & Head, Corp. Development
Sold 1.2% of holdings ($22.1M position)727,439 shares left0.3x usual sizeFiling
- 7 Form 4 sale Juno Therapeutics, Inc.Plan not statedDec 21, 2017 +171 days
Sold 8,750 shares at $44.77 ($392k)
Harr Steve, CFO & Head, Corp. Development
Sold 1.1% of holdings ($34.6M position)763,332 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2017 | Dec 22, 2017 | Juno Therapeutics, Inc. | CFO & Head, Corp. Development | Form 4 sale | 8,750 | $392k | 1.1% | Plan not stated | SEC |
| Jul 3, 2017 | Jul 5, 2017 | Juno Therapeutics, Inc. | CFO & Head, Corp. Development | Form 4 sale | 8,750 | $263k | 1.2% | Plan not stated | SEC |
| Jun 27, 2017 | Jun 29, 2017 | Juno Therapeutics, Inc. | CFO & Head, Corp. Development | Form 4 sale | 8,750 | $263k | 1.2% | Plan not stated | SEC |
| Jun 10, 2016 | Jun 13, 2016 | Juno Therapeutics, Inc. | CFO & Head, Corp. Development | Form 4 sale | 30,000 | $1.3M | 4.1% | Plan not stated | SEC |
| Mar 4, 2016 | Mar 4, 2016 | Juno Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $225k | 0.7% | Plan not stated | SEC |
| Mar 1, 2016 | Mar 2, 2016 | Juno Therapeutics, Inc. | Officer | Form 4 sale | 30,000 | $1.1M | 3.9% | Plan not stated | SEC |
| Dec 10, 2015 | Dec 11, 2015 | Juno Therapeutics, Inc. | Officer | Form 4 sale | 35,000 | $1.6M | 4.4% | Plan not stated | SEC |